| Authors: |
Agbenyega T; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana., Schuind AE; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA. Electronic address: aschuind@path.org., Adjei S; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana., Antony K; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Aponte JJ; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Buabeng PBY; Malaria Research Center, Agogo Presbyterian Hospital/Kwame Nkrumah University of Science and Technology, Agogo, Ghana., Clemens JD; International Vaccine Institute, Seoul, South Korea; Center for Vaccine Innovation, Seoul, South Korea; UCLA Fielding School of Public Health, Los Angeles, CA, USA., Hossain L; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Kemp TJ; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Mercer LD; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Pinto LA; HPV Serology Laboratory, Vaccine, Immunity, and Cancer Directorate, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Qadri F; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh., Sukraw K; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Bhat N; PATH, Center for Vaccine Innovation and Access, Seattle, WA, USA., Zaman K; Infectious Diseases Division, International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh. |
